seed
Stage
2020
Founded
2
Investors
About
Telum Therapeutics is a German biotech company developing novel anti-infectives to combat antimicrobial resistance. Their lead program focuses on a new class of antibiotics for multi-drug resistant Gram-negative bacterial infections.
Explore Telum Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.